Quarterly Activities/Appendix 4C Cash Flow Report
Filed with ASX ·
6ix is reading this filing.
Optiscan Imaging Limited on 6ix
Earlier from Optiscan Imaging
- Optiscan Lodges U.S. FDA 510(k) Submission for InVue
- Optiscan Lodges U.S. FDA 510(k) Submission for InForm
- Significant Milestone Reached in ACL Digital Pathology Study
- Optiscan Initiates Head and Neck Cancer Study in the US
- Preliminary Final Report
Follow Optiscan Imaging into a list and get an email when it puts out news.
Follow Optiscan Imaging